REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Argentopharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: ARGENTOPHARMA Patika Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Argentopharma Bt. is an enterprise in Hungary, with the main office in Lorinci. The company operates in the Pharmacies and Drug Stores sector. The company was established on November 13, 1995. 3 (2023) employees currently work for Argentopharma Bt.. In 2022, the company reported a net sales revenue increase of 17.04%. Its’ total assets recorded a growth of 72.46%. Argentopharma Bt.’s net profit margin increased by 1.74% in 2022.

Headquarters
Szabadsag ter 2/A
Lorinci; Heves; Postal Code: 3021

Contact Details: Purchase the Argentopharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Argentopharma Bt. report to view the information.
Outstanding Shares:
Purchase the Argentopharma Bt. report to view the information.
Registered Capital:
Purchase the Argentopharma Bt. report to view the information.
Incorporation Date:
November 13, 1995
Key Executives
Purchase this report to view the information.
Executive Officer
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Argentopharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
17.04%▲
Total operating revenue
17.45%▲
Operating profit (EBIT)
129.29%▲
EBITDA
116.64%▲
Net Profit (Loss) for the Period
113.96%▲
Total assets
72.46%▲
Total equity
56.31%▲
Operating Profit Margin (ROS)
2.07%▲
Net Profit Margin
1.74%▲
Return on Equity (ROE)
9.71%▲
Quick Ratio
0.87%▲
Cash Ratio
0.2%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo